Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Fulphila |
| Active Ingredient: | Pegfilgrastim 10mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Mylan New Zealand Limited |
| Manufacturer: | Biocon Limited, Bangalore, India |
| Product: | Tapclob |
| Active Ingredient: | Clobazam 1mg/mL |
| Dosage Form: | Oral suspension |
| New Zealand Sponsor: | Max Health Limited |
| Manufacturer: | Macarthys Laboratories Limited T/A Martindale Pharma, Romford, United Kingdom |
| Product: | Tapclob |
| Active Ingredient: | Clobazam 2mg/mL |
| Dosage Form: | Oral suspension |
| New Zealand Sponsor: | Max Health Limited |
| Manufacturer: | Macarthys Laboratories Limited T/A Martindale Pharma, Romford, United Kingdom |
Dated this 24th day of February 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on the 11th day of September 2013).